The molecular mechanisms of epigenetic therapies: LTRs and TINATs
Recognizing clonal hematopoiesis – diagnostic challenges and clinical relevance
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax
Overview of the T-SPOT assay for diagnosing tuberculosis and cytomegalovirus